Phase 3 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Trial Profile

Phase 3 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Poliovirus vaccine Intravacc/WHO (Primary)
  • Indications Poliomyelitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Nov 2017 According to a Sinovac Biotech media release, this trial was initiated in the third quarter of 2017 and expected to be completed in 2018.
    • 22 Nov 2017 Status changed from planning to recruiting, as reported in a Sinovac Biotech media release.
    • 08 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top